Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 63 results for "ranbaxy lab"

Ranbaxy Laboratories Owners Deliberately Buried Information Fr...

August 11, 2016 By Alex Keown , Breaking News Staff MUMBAI, India More sour news has surfaced from the Daiichi Sankyo acquisition of Ranbaxy Labs ( RANBAXY.BO ) as new details emerged of the Ranbaxy owners deliberately ... Pharma Live, 2 weeks ago

1 images for "ranbaxy lab"

Money Control, 6 months ago

Gripping tale of an iconic businessman

Over the years, Mr Singh has got in and out of innumerable businesses, cutting across sectors. He is one businessman who I have always found to be in a start-up mode, says Bhupesh Bhandari. Analjit Singh will now become a shareholder in HDFC Life. He will also get richer by Rs 850 crore (Rs 8.5 billion), which is the non-compete fee he will receive for not floating a life insurance venture for the next four years. It is not clear what he will do with this money. Maybe he will invest it in his ...
 Rediff.com1 week ago

Pharmalot, Pharmalittle: North Korea's Neo-Viagra has the same ingredient as the real thing

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is somewhat unsettled, but we plan to hang with our short people and catch up ...
 StatNews.com2 weeks ago

FDA Warns Chinese Drugmaker Xiamen Origin Biotech Over Making False Statements to Regulators

By Alex Keown , Breaking News Staff WASHINGTON The U.S. Food and Drug Administration has a warning for Chinese company Xiamen Origin Biotech —don't lie. A January inspection of that company's facilities in China revealed a number of ...
 BioSpace3 weeks ago FDA Warns Chinese Drugmaker Over Making False Statements to Regulators  Pharma Live3 weeks ago
Pharmaceutical Online

Data Integrity: Surveying The Current Regulatory Landscape

By Barbara Unger , Unger Consulting Inc. Failures in data integrity break the essential trust that regulators have withmanufactures of medicinal products. Regulatory authorities cannot review all the data that firms generate during the ...
 Pharmaceutical Online3 weeks ago

Dermatological Drugs Market Forecast 2016-2026

/PRNewswire/ -- Analysis of the Current Trends and Pipeline Opportunities in the Psoriasis, Skin Infection, Acne and Dermatitis Markets Including Current Products Such as Humira, Stelara, Enbrel, Remicade, Taltz, Cosentyx, Cubicin, Canesten, ...
 BioSpace3 weeks ago Drug Delivery Technologies Market Forecast 2016-2026  BioSpace1 month ago Antibacterial Drugs: World Industry and Market Prospects 2016-2026  AndhraNews.net1 month ago

China's Fosun Close to Deal for India's Gland Pharma

Abbott labs (NYSE:ABT) Intraday Stock Chart Today : Thursday 28 July 2016 HONG KONG—China's Fosun Group is near to buying control of Gland Pharma Ltd. from shareholders including KKR & Co. in a deal that values the Indian pharmaceutical ...
 Investors Hub1 month ago

Global Active Pharmaceutical Ingredients Market, 2022 - Market to Reach $175 Billion - Research and Markets

/PRNewswire/ -- Research and Markets has announced the addition of the report to their offering. Major players in the API market include Teva Active Pharmaceutical Industries Limited ( Israel ), Ranbaxy Laboratories ( India ), Dr. Reddy's Lab ( ...
 BioSpace1 month ago


The Pharmabiz study of the performances of India's top 100 listed pharmaceutical companies during 2015-16 brings out a complex profile of this key industry of the country. The net sales of these 100 companies increased by 10.3 per cent to Rs.
 PharmaBiz1 month ago Suven Life gets patent and other top pharma news  India Infoline1 month ago Net sales of 100 top pharma cos move up by 10.3% to Rs. 1.9 lakh crore in 2015-16  PharmaBiz1 month ago

Following Revelations of ???Flawed Studies??? in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG and Teva

By Alex Keown , Breaking News Staff LONDON -- The European Medicines Agency recommended suspending the sale of dozens of generic medications, including several made by Novartis AG ( NVS ) and Teva ( TEVA ), following concerns over ...
 BioSpace1 month ago Following Revelations of Flawed Studies in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG and Teva  Pharma Live1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less